Background: Treatment for locally advanced differentiated thyroid cancer is surgery followed by radioiodine while the role of adjuvant external beam radiotherapy (EBRT) is debated. Methods: The panel of the Italian Association of Radiotherapy and Clinical Oncology developed a clinical recommendation on the addition of EBRT to radioiodine after surgery for locally advanced differentiated thyroid cancer by using the Grades of Recommendation, Assessment, Development, and Evaluation methodology and the Evidence to Decision framework. A systematic review with meta-analysis about this topic was conducted with a focus on outcome of benefits and toxicity. Results: Locoregional control was improved by EBRT while no considerable toxicity impact was reported. Conclusion: The panel judged uncertain the benefit/harms balance; final recommendation was conditional both for EBRT + radioiodine and radioiodine alone in the adjuvant setting.

Dicuonzo, S., Pedretti, S., Mangoni, M., Monari, F., Fanetti, G., Borsatti, E., et al. (2021). Adjuvant radiotherapy and radioiodine treatment for locally advanced differentiated thyroid cancer: systematic review and meta-analysis. TUMORI, 107(6), 489-497 [10.1177/0300891621996817].

Adjuvant radiotherapy and radioiodine treatment for locally advanced differentiated thyroid cancer: systematic review and meta-analysis

Arcangeli S.;
2021

Abstract

Background: Treatment for locally advanced differentiated thyroid cancer is surgery followed by radioiodine while the role of adjuvant external beam radiotherapy (EBRT) is debated. Methods: The panel of the Italian Association of Radiotherapy and Clinical Oncology developed a clinical recommendation on the addition of EBRT to radioiodine after surgery for locally advanced differentiated thyroid cancer by using the Grades of Recommendation, Assessment, Development, and Evaluation methodology and the Evidence to Decision framework. A systematic review with meta-analysis about this topic was conducted with a focus on outcome of benefits and toxicity. Results: Locoregional control was improved by EBRT while no considerable toxicity impact was reported. Conclusion: The panel judged uncertain the benefit/harms balance; final recommendation was conditional both for EBRT + radioiodine and radioiodine alone in the adjuvant setting.
Articolo in rivista - Articolo scientifico
GRADE recommendation; radioiodine; radiotherapy; Thyroid cancer;
English
489
497
9
Dicuonzo, S., Pedretti, S., Mangoni, M., Monari, F., Fanetti, G., Borsatti, E., et al. (2021). Adjuvant radiotherapy and radioiodine treatment for locally advanced differentiated thyroid cancer: systematic review and meta-analysis. TUMORI, 107(6), 489-497 [10.1177/0300891621996817].
Dicuonzo, S; Pedretti, S; Mangoni, M; Monari, F; Fanetti, G; Borsatti, E; Lombardi, D; Vianello, F; Iacobone, M; Corvo, R; Magrini, S; Pappagallo, G; Arcangeli, S; D'Angelillo, R
File in questo prodotto:
File Dimensione Formato  
Dicuonzo_TJ2021.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 1.29 MB
Formato Adobe PDF
1.29 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/353541
Citazioni
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
Social impact